Although STAT3 directly activates cyclin D1, their findings suggest that STAT3 may also influence cyclin D1 expression through PAK2, introducing an alternative mechanism that could drive AdCC cell proliferation. Here, PAK2 is linked to adrenocortical carcinoma, hereditary.